We are live on ! Find out more
LXRX icon

Lexicon Pharmaceuticals
LXRX

107 hedge funds and large institutions have $710M invested in Lexicon Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 29 increasing their positions, 29 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more call options, than puts

Call options by funds: $2.58M | Put options by funds: $1.35M

70% more capital invested

Capital invested by funds: $417M → $710M (+$293M)

12% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 26

1% more funds holding

Funds holding: 106 → 107 (+1)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 29

2.25% less ownership

Funds ownership: 86.24% → 83.99% (-2.2%)

Holders
107
Holders Change
+1
Holders Change %
+0.94%
% of All Funds
1.88%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
29
Increased
29
Reduced
29
Closed
26
Calls
$2.58M
Puts
$1.35M
Net Calls
+$1.22M
Net Calls Change
+$437K

Top Buyers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$8.4M
2
BlackRock
BlackRock
New York
+$6.72M
3
Nomura Holdings
Nomura Holdings
Japan
+$6.36M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.57M
5
Two Sigma Investments
Two Sigma Investments
New York
+$3.26M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$17.8M
2
Morgan Stanley
Morgan Stanley
New York
-$9.52M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$8.53M
4
Millennium Management
Millennium Management
New York
-$5.16M
5
Renaissance Technologies
Renaissance Technologies
New York
-$4.73M
Name Holding Trade Value Shares
Change 		Change in
Stake
EI
101
Ellevest Inc
New York
$2K – – –
Nisa Investment Advisors
102
Nisa Investment Advisors
Missouri
$822 +$942K +136,090 +3,481%
AIG
103
American International Group
New York
$170 +$34.5K +4,984 +21%
Walleye Capital
104
Walleye Capital
New York
$102 +$120K +17,400 New
PAMU
105
Pictet Asset Management (UK)
United Kingdom
– -$3.4M -994,476 Closed
IHAM
106
Integral Health Asset Management
New York
– -$1.03M -300,000 Closed
Simplex Trading
107
Simplex Trading
Illinois
– -$906K -130,808 -84%
Susquehanna International Group
108
Susquehanna International Group
Pennsylvania
– -$622K -89,796 Closed
SSA
109
Schonfeld Strategic Advisors
New York
– -$259K -75,700 Closed
Connor, Clark & Lunn Investment Management (CC&L)
110
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$165K -48,249 Closed
Arrowstreet Capital
111
Arrowstreet Capital
Massachusetts
– -$164K -47,849 Closed
Group One Trading
112
Group One Trading
Illinois
– -$257K -37,089 Closed
QSS
113
Quantitative Systematic Strategies
Florida
– -$117K -34,086 Closed
GC
114
Globeflex Capital
California
– -$98K -28,667 Closed
TSS
115
Two Sigma Securities
New York
– -$68K -20,003 Closed
SG Americas Securities
116
SG Americas Securities
New York
– -$68K -19,786 Closed
Dimensional Fund Advisors
117
Dimensional Fund Advisors
Texas
– -$57K -16,778 Closed
BCM
118
Bayesian Capital Management
New York
– -$56K -16,300 Closed
Prudential Financial
119
Prudential Financial
New Jersey
– -$52K -15,219 Closed
IFG
120
Investors Financial Group
Minnesota
– -$49K -14,400 Closed
Wolverine Trading
121
Wolverine Trading
Illinois
– -$86.2K -12,444 Closed
Macquarie Group
122
Macquarie Group
Australia
– -$40K -11,697 Closed
SW
123
SteelPeak Wealth
California
– -$34K -10,000 Closed
WC
124
Wexford Capital
Florida
– -$14K -4,000 Closed
JPLA
125
Joseph P. Lucia & Associates
New York
– -$3K -1,000 Closed
2 3 4
5
6

LXRX Hedge Fund Activity: Q1 2021 in Review

107 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Lexicon Pharmaceuticals (LXRX) for Q1 2021, worth a combined $710M — up 70% from $417M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new LXRX positions and 26 closed out — a net gain of 3 holders — while 29 added to existing stakes and 29 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $8.4M. The largest seller was BVF Inc, cutting an estimated $17.8M.

  • 107 institutional investors held Lexicon Pharmaceuticals (LXRX) as of Q1 2021, up from 106 in Q4 2020.
  • Funds reported $710M of Lexicon Pharmaceuticals stock for Q1 2021, up 70% quarter-over-quarter.
  • 29 funds opened new Lexicon Pharmaceuticals positions in Q1 2021 and 26 closed out, a net change of +3 holders.
  • The largest Lexicon Pharmaceuticals buyer in Q1 2021 was D.E. Shaw & Co, an estimated $8.4M added.
  • The largest Lexicon Pharmaceuticals seller in Q1 2021 was BVF Inc, an estimated $17.8M sold.

Based on aggregated 13F filings for Q1 2021.